Status:
UNKNOWN
Correlation Between Fluorodeoxyglucose (FDG) and FLT Uptake and Gene-Expression Oncotype Assay in Patients With Breast Cancer
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-86 years
Brief Summary
In the current study FDG (Fluorodeoxyglucose) uptake, FLT uptake (F18-Fluoro-3'-deoxythymidine) and their ratios will be correlated with the risk score results of the Oncotype gene-expression assay in...
Detailed Description
Several publications have addressed the role of PET imaging for biological characterization of breast cancer. A modest but significant correlation was reported between tumor grading and FDG uptake. Fe...
Eligibility Criteria
Inclusion
- Newly diagnosed patients with breast cancer
- clinically nodal negative
- prior to surgery and/or treatment
- age over 18 years
Exclusion
- Age under 18
- Pregnancy
- Previous therapy for breast cancer
- Clinical or histological evidence of nodal involvement or other proven metastatic sites
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2010
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00688337
Start Date
June 1 2008
End Date
June 1 2010
Last Update
June 2 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Nuclear Medicine, Tel Aviv Sourasky Medical Center
Tel Aviv, Israel, 64239